Articles

TGA has issued 10 infringement notices totalling $71,280 to Gezond Pty Ltd and 3 registered pharmacists.

The TGA, working with the NSW Police Force and other state and Commonwealth enforcement agencies, supported coordinated enforcement operations targeting a company allegedly involved in the importation, storage and distribution of vaping goods, nicotine pouches, illicit tobacco and other unlawful products.

TGA with the assistance of the NSW Police has seized more than $120,000 of illicit peptide and anabolic steroid products from 2 residential premises in New South Wales allegedly linked to a social media influencer.

The TGA is updating information for acceptable intake of nitrosamine impurities in medicines.

Two Victorian residents have been charged with additional offences following an Australian Border Force led investigation into the alleged importation of Performance and Image Enhancing Drugs into Australia.

We are seeking feedback on our proposal to improve information sharing about the safety, quality, and performance of medical devices.

The Therapeutic Goods Administration (TGA) is aware of media reports about the safety of defibrillator devices used in some ambulance services and healthcare facilities.

Information for health professionals about medicines with safety related updates to their Product Information.

As part of a coordinated enforcement action, 4 search warrants were simultaneously executed at 2 retail premises in Kippax, a retail premises in Belconnen, and a residence in north Canberra.

We have commenced proceedings in the Federal Court of Australia against Better Leaf Pty Ltd (Better Leaf), Better Life Aussie Pty Ltd (Better Life), and their sole director for the alleged unlawful advertising of medicinal cannabis.

We are reviewing new information that has raised concerns regarding the integrity and reliability of the clinical trial data that supported the approval of TAVNEOS (avacopan) in Australia.

TGA has issued an infringement notice, to the value of $19,800, to Cellife Health Care Pty Ltd (Cellife) for the alleged supply of a listed medicine that did not comply with an applicable standard, in contravention of the Therapeutic Goods Act 1989

Following a public consultation process between 24 November 2025 – 10 February 2026, the TGA has adopted 23 international scientific guidelines

Product warnings across the glucagon-like-peptide-1 receptor agonist (GLP-1 RA) class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder.

We have added our recent decisions to the list of Australian manufacturers licensed by the TGA.

Information for health professionals about medicines with safety related updates to their Product Information.

Unapproved peptide products are being advertised as delivering fast health results, but they can pose serious health risks to consumers.

New regulations are now in place across Australia to protect public health, by restricting access to nicotine pouches.

The TGA, in partnership with NT Health, Northern Territory Police Force and the Northern Territory Department of Trade, Business and Asian Relations, conducted a targeted multi-agency enforcement operation across three premises in Darwin.

TGA has released a new information page relating to the availability of s 9D(1) of the Act to correct information in the ARTG about listed medicines.

We have issued 5 infringement notices totalling $99,000 to Acacia Pharmacy Pty Ltd for the alleged unlawful importation of unapproved melatonin products, in contravention of the Therapeutic Goods Act 1989.

In March 2026, the Therapeutic Goods Administration (TGA) issued 3 infringement notices totalling $59,400 to Queensland-based company Canngea Pty Ltd.

We've launched a series of interactive e-learning modules designed to help stakeholders understand their regulatory obligations.

Cases of liver injury associated with herbal preparations containing Withania somnifera, commonly known as Ashwagandha, continue to be reported both in Australia and internationally.

We have issued 3 infringement notices totalling $11,880 to a nurse for the alleged unlawful importation of unapproved cosmetic injectables, which is illegal under the Therapeutic Goods Act 1989 (the Act).